Héctor Diego de Diego

Dr. Héctor Diego de Diego

Hospital General Universitario Gregorio Marañón
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
GPGonzalo Salazar de Pablo
Gonzalo Salazar de Pablo
SWScott W. Woods
Scott W. Woods
GDGeorgia Drymonitou
Georgia Drymonitou
HDHéctor Diego de Diego
Héctor Diego de Diego
PFPaolo Fusar-Poli
Paolo Fusar-Poli
(1) The consistency and magnitude of the prevalence of Clinical High-Risk for Psychosis (CHR-P) individuals are undetermined, limiting efficient detection of cases. We aimed to evaluate the prevalence of CHR-P individuals systematically assessed in the general population or clinical samples. (2) PRISMA/MOOSE-compliant (PROSPERO: CRD42020168672) meta-analysis of multiple databases until 21/01/21: a random-effects model meta-analysis, heterogeneity analysis, publication bias and quality assessment, sensitivity analysis—according to the gold-standard CHR-P and pre-screening instruments—leave-one-study-out analyses, and meta-regressions were conducted. (3) 35 studies were included, with 37,135 individuals tested and 1554 CHR-P individuals identified (median age = 19.3 years, Interquartile range (IQR) = 15.8–22.1; 52.2% females, IQR = 38.7–64.4). In the general population (k = 13, n = 26,835 individuals evaluated), the prevalence of the CHR-P state was 1.7% (95% Confidence Interval (CI) = 1.0–2.9%). In clinical samples (k = 22, n = 10,300 individuals evaluated), the prevalence of the CHR-P state was 19.2% (95% CI = 12.9–27.7%). Using a pre-screening instrument was associated with false negatives (5.6%, 95% CI = 2.2–13.3%) and a lower CHR-P prevalence (11.5%, 95% CI = 6.2–20.5%) compared to using CHR-P instruments only (28.5%, 95% CI = 23.0–34.7%, p = 0.003). (4) The prevalence of the CHR-P state is low in the general population and ten times higher in clinical samples. The prevalence of CHR-P may increase with a higher proportion of females in the general population and with a younger population in clinical samples. The CHR-P state may be unrecognized in routine clinical practice. These findings can refine detection and preventive strategies.

28 July 2021 in European Psychiatry
Verified
Journal Article
Open access
PDF file
GPGonzalo Salazar de Pablo
Gonzalo Salazar de Pablo
CDCathy Davies
Cathy Davies
HDHéctor Diego de Diego
Héctor Diego de Diego
MSMarco Solm
Marco Solm
Jae Il ShinJae Il Shin
Jae Il Shin
PFPaolo Fusar-Poli
Paolo Fusar-Poli
Background: Individuals at clinical high risk of psychosis (CHR-P) recruited in randomized clinical trials (RCTs) and observational cohorts may display a different enrichment and hence risk of transition to psychosis. No meta-analysis has ever addressed this issue. Methods: “Preferred Reporting Items for Systematic reviews and Meta-Analyses” (PRISMA) and “Meta-analysis Of Observational Studies in Epidemiology” (MOOSE)–compliant meta-analysis. PubMed and Web of Science were searched until November 2020 (PROSPERO:CRD42021229223). We included nonoverlapping longitudinal studies (RCTs-control condition and observational cohorts) reporting the transition to psychosis in CHR-P individuals. The primary effect size measure was the cumulative risk of transition at 0.5, 1, and 2 years follow-up in RCTs compared to observational cohorts. Random effects meta-analyses, heterogeneity assessment, quality assessment, and meta-regressions were conducted. Results: Ninety-four independent studies (24 RCTs, 70 observational cohorts) and 9,243 individuals (mean age = 20.1 ± 3.0 years; 43.7% females) were included. The meta-analytical risk of transitioning to psychosis from a CHR-P stage was 0.091 (95% confidence intervals [CI] = 0.068–0.121) at 0.5 years, 0.140 (95% CI = 0.101–0.191) at 1 year and 0.165 (95% CI = 0.097–0.267) at 2 years follow-up in RCTs, and 0.081 (95% CI = 0.067–0.099) at 0.5 years, 0.138 (95% CI = 0.114–0.167) at 1 year, and 0.174 (95% CI = 0.156–0.193) at 2 years follow-up in observational cohorts. There were no between-group differences in transition risks (p > 0.05). The proportion of CHR-P individuals with substance use disorders (excluding alcohol and cannabis) was higher in observational cohorts (16.8, 95% CI = 13.3–21.0%) than in RCTs (3.4, 95% CI = 0.8–12.7%; p = 0.018). Conclusions: There is no meta-analytic evidence supporting sampling biases in RCTs of CHR-P individuals. Further RCTs are needed to detect effective interventions to prevent psychosis in this at-risk group.

1 March 2023
Verified
Journal Article
Open access
HDHéctor Diego de Diego
Héctor Diego de Diego
LGLaura Santos Garcia
Laura Santos Garcia
MGMartin Rodriguez Giron
Martin Rodriguez Giron
BCBeatriz Lopez Carpintero
Beatriz Lopez Carpintero
TMTeresa Velasco Moran
Teresa Velasco Moran
ICIgnacio Garcia Cabeza
Ignacio Garcia Cabeza
Introduction. COVID-19 led to a reorganization of health care in Madrid. The objective of this study is to describe the sociodemographic and clinical profile of psychiatric patients admitted to Gregorio Marafion Hospital during lockdown.Methods. A retrospective cross-sectional study was con-ducted and data were collected from all admissions to our psychiatric unit from March 15 to May 30, 2019 and 2020. A protocol was developed including clinical and sociodemo-graphic variables and a series of variables referring to the year prior to admission. In addition to descriptive statistics, we used Student's t test to compare quantitative variables and x2 for qualitative variables.Results. In 2020, the attended population increased by 312.5%, while admissions increased only 2.5%. Socioeconomic status was significantly lower in 2020 (x2=18.041; p=0.001). The number of previous hospitalizations was significantly higher in 2019 patients (t=2,147; p=0.032), but the variables that measured only the previous year reflected more time of psychopathology (x(2)=7.407; p=0.025) and hospitalization (x(2)=16,765; p = 0.000) in 2020, as well as more dysfunc-tional family relationships (x(2)=33.819; p=0.000) and less autonomy (x(2)=6.387; p=0.041). The index admission was significantly shorter in 2020 (t=2.977; p=0.003). There were also significant differences in the reason for admission, diagnosis, and substance use.Conclusions. There was a decrease in attendance to emergency services and the need for hospital admissions and an increase in the proportion of admissions in people with an unfavorable social and family background and with psychotic and bipolar disorders.